Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
Fumiya WatanabeShota KaburakiKoji FuruuchiFumiko UesugiKeiji FujiwaraYoshiaki TanakaTakashi YoshiyamaYuji ShiraishiAtsuyuki KurashimaKen OhtaKazuhiko HanadaKozo MorimotoPublished in: Infection (2022)
An ethambutol dosage of 12.5 mg/kg/day or less in guideline-based chemotherapy may reduce optic neuropathy without worsening clinical outcomes.